Cargando…
Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol
INTRODUCTION: This article describes the protocol of an Ebola vaccine clinical trial which investigates the safety and immunogenicity of a two-dose prophylactic Ebola vaccine regimen comprised of two Ebola vaccines (Ad26.ZEBOV and MVA-BN-Filo) administered 56 days apart, followed by a booster vaccin...
Autores principales: | Larivière, Ynke, Zola, Trésor, Stoppie, Elke, Maketa, Vivi, Matangila, Junior, Mitashi, Patrick, De Bie, Jessie, Muhindo-Mavoko, Hypolite, Van geertruyden, Jean-Pierre, Van Damme, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479954/ https://www.ncbi.nlm.nih.gov/pubmed/34588237 http://dx.doi.org/10.1136/bmjopen-2020-046835 |
Ejemplares similares
-
Algorithm for the support of non-related (serious) adverse events in an Ebola vaccine trial in the Democratic Republic of the Congo
por: Lemey, Gwen, et al.
Publicado: (2021) -
Use of Iris Scanning for Biometric Recognition of Healthy Adults Participating in an Ebola Vaccine Trial in the Democratic Republic of the Congo: Mixed Methods Study
por: Zola Matuvanga, Trésor, et al.
Publicado: (2021) -
Low seroprevalence of Ebola virus in health care providers in an endemic region (Tshuapa province) of the Democratic Republic of the Congo
por: Zola Matuvanga, Trésor, et al.
Publicado: (2023) -
Accuracy of malaria rapid diagnosis test Optimal-IT® in Kinshasa, the Democratic Republic of Congo
por: Muhindo, Hypolite Mavoko, et al.
Publicado: (2012) -
Challenges to COVID-19 vaccine introduction in the Democratic Republic of the Congo – a commentary
por: Zola Matuvanga, Trésor, et al.
Publicado: (2022)